Twelve months after releasing a roadmap to shift away from animal testing requirements, the FDA has declared mission ...

It’s not just "business as usual"—it’s a high-stakes tug-of-war between cutting-edge ethics and the complex reality of ...

Every year, millions of animals are used in laboratories, and for many people, the image is immediate and uncomfortable: ...

Add Yahoo as a preferred source to see more of our stories on Google. Governments have announced plans to reduce the number of animals, such as mice, used in experimental procedures. (Philip Cheung ...

The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal antibody therapies and other drugs and biological products “with ...

A social media post from the US Food and Drug Administration this week shows a big-eyed macaque staring out from behind bars. “Some drugs use 144 monkeys on average for preclinical testing,” the post ...

Alternative methods to the use of animals in pharmaceutical testing are becoming more used and accepted. Laura Lotfi of ...

Animal testing in Connecticut rakes in millions in federal dollars each year at colleges and universities but, the National Institutes of Health recently announced it is pivoting from using just ...

Merck KGaA plans to phase out most animal testing in favor of advanced human-relevant models, while OZMOSI and Planview are integrating structured clinical datasets with AI-driven R&D planning ...

Carlin is a vice president at Pathway Policy Group and a veterinarian. Paragas is the CEO and founder of DVLP Medicines and a virologist. The Food and Drug Administration’s recent decision to phase ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued new guidance on how marketing applicants can use non-animal data in their applications. The move comes on the heels of a ...

Criticism of animal research − usually associated with the progressive left − has grown in recent years, as the practice is blamed for the slow pace of drug development. The Food and Drug ...